carbidopa monohydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
APO-LEVODOPA/CARBIDOPA 250/25 levodopa 250 mg and carbidopa (as monohydrate) 25 mg tablet bottle
AUST R: 275986
Active ingredients:
carbidopa monohydrate
levodopa

Dosage form:
Tablet, uncoated

Sponsor:
Generic Partners Pty Ltd

Phone:
1300 927 769

From
29 Jan 2021
to
28 May 2021

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing

SINEMET CR levodopa/carbidopa 200 mg/50 mg modified release tablet bottle
AUST R: 171694
Active ingredients:
carbidopa monohydrate
levodopa

Dosage form:
Tablet, modified release

Sponsor:
ORGANON PHARMA PTY LTD

Phone:
1800023135

Deletion from market:
04 Jan 2021

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Other

Management action:
This product is being replaced by SINEMET CR 200/50 levodopa/carbidopa 200 mg/50 mg modified release tablet bottle (AUST R 326195).